Literature DB >> 20924309

Clinicopathological features and prognosis of mucinous cystic neoplasm with ovarian-type stroma: a multi-institutional study of the Japan pancreas society.

Kenji Yamao1, Akio Yanagisawa, Kuniyuki Takahashi, Wataru Kimura, Ryuichiro Doi, Noriyoshi Fukushima, Nobuyuki Ohike, Michio Shimizu, Takashi Hatori, Bunsei Nobukawa, Michio Hifumi, Yuji Kobayashi, Kosuke Tobita, Satoshi Tanno, Masanori Sugiyama, Yoshihiro Miyasaka, Toshio Nakagohri, Taketo Yamaguchi, Keiji Hanada, Hideki Abe, Minoru Tada, Naotaka Fujita, Masao Tanaka.   

Abstract

OBJECTIVE: The aim of this study was to elucidate the clinicopathological features and prognosis of mucinous cystic neoplasms (MCNs).
MATERIALS AND METHODS: We performed a multi-institutional, retrospective study on a collected series of patients with MCN pathologically defined by ovarian-type stroma. Clinicopathological features and prognosis were investigated. RESULT: Mucinous cystic neoplasm was confirmed in 156 cases, including 129 adenomas (82.7%) and 21 noninvasive (13.4%) and 6 invasive carcinomas (3.9%). Patients with MCN were exclusively women (98.1%) with the mean age of 48.1 years. All but 1 MCN were in the pancreatic body/tail region with a mean size of 65.3 mm. Communication between the cyst and the pancreatic duct was found in 18.1%. The 3-, 5-, and 10-year survival rates were 97.6%, 96.6%, and 96.6%, respectively. A significant difference in the survival rates was observed between adenomas and carcinomas and between minimally invasive carcinomas and invasive carcinomas. Cyst diameter and presence of mural nodule were predictive of malignant MCN.
CONCLUSIONS: Mucinous cystic neoplasm is a rare but distinctive pancreatic cystic neoplasm with a favorable overall prognosis. All MCNs should be resected to prevent malignant changes but can be observed for an appropriate time when the lesion is small without the presence of mural nodules.

Entities:  

Mesh:

Year:  2011        PMID: 20924309     DOI: 10.1097/MPA.0b013e3181f749d3

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  63 in total

Review 1.  Diagnosis and management of cystic lesions of the pancreas.

Authors:  William R Brugge
Journal:  J Gastrointest Oncol       Date:  2015-08

2.  Cystic Neoplasm of the Pancreas.

Authors:  Alessandra Pulvirenti; Giovanni Marchegiani; Giuseppe Malleo; Alex Borin; Valentina Allegrini; Claudio Bassi; Roberto Salvia
Journal:  Indian J Surg       Date:  2015-10-28       Impact factor: 0.656

Review 3.  Diagnosis and management of pancreatic cystic neoplasms.

Authors:  Mathew James Keegan; Bharat Paranandi
Journal:  Frontline Gastroenterol       Date:  2019-03-01

Review 4.  Natural History of Pancreatic Cysts.

Authors:  Alexander Larson; Richard S Kwon
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

5.  Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.

Authors:  Hirofumi Harima; Seiji Kaino; Shuhei Shinoda; Michitaka Kawano; Shigeyuki Suenaga; Isao Sakaida
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

Review 6.  Surgical Management of Pancreatic Cysts: A Shifting Paradigm Toward Selective Resection.

Authors:  Jon M Gerry; George A Poultsides
Journal:  Dig Dis Sci       Date:  2017-04-18       Impact factor: 3.199

7.  Differential Diagnosis of Pancreatic Epidermoid Cyst Without a Solid Component (Residual Splenic Tissue) vs. Mucinous Cystic Neoplasm.

Authors:  Kousei Ishigami; Akihiro Nishie; Hiroyuki Irie; Yoshiki Asayama; Yasuhiro Ushijima; Yukihisa Takayama; Daisule Okamoto; Nobuhiro Fujita; Takao Ohtsuka; Tetsuhide Ito; Naoki Mochidome; Hiroshi Honda
Journal:  J Gastrointest Cancer       Date:  2019-03

8.  Prognosis of minimally invasive carcinoma arising in mucinous cystic neoplasms of the pancreas.

Authors:  Gloria H Lewis; Huamin Wang; Andrew M Bellizzi; Alison P Klein; Frederic B Askin; Lauren Ende Schwartz; Richard D Schulick; Christopher L Wolfgang; John L Cameron; Eileen M O'Reilly; Kenneth H Yu; Ralph H Hruban
Journal:  Am J Surg Pathol       Date:  2013-04       Impact factor: 6.394

9.  MIB-1 labeling index, Ki-67, is an indicator of invasive intraductal papillary mucinous neoplasm.

Authors:  Tatsuo Shimura; Yasuhide Kofunato; Ryo Okada; Rei Yashima; Koji Okada; Kenichiro Araki; Yasuo Hosouchi; Hiroyuki Kuwano; Seiichi Takenoshita
Journal:  Mol Clin Oncol       Date:  2016-05-20

10.  A combination of molecular markers and clinical features improve the classification of pancreatic cysts.

Authors:  Simeon Springer; Yuxuan Wang; Marco Dal Molin; David L Masica; Yuchen Jiao; Isaac Kinde; Amanda Blackford; Siva P Raman; Christopher L Wolfgang; Tyler Tomita; Noushin Niknafs; Christopher Douville; Janine Ptak; Lisa Dobbyn; Peter J Allen; David S Klimstra; Mark A Schattner; C Max Schmidt; Michele Yip-Schneider; Oscar W Cummings; Randall E Brand; Herbert J Zeh; Aatur D Singhi; Aldo Scarpa; Roberto Salvia; Giuseppe Malleo; Giuseppe Zamboni; Massimo Falconi; Jin-Young Jang; Sun-Whe Kim; Wooil Kwon; Seung-Mo Hong; Ki-Byung Song; Song Cheol Kim; Niall Swan; Jean Murphy; Justin Geoghegan; William Brugge; Carlos Fernandez-Del Castillo; Mari Mino-Kenudson; Richard Schulick; Barish H Edil; Volkan Adsay; Jorge Paulino; Jeanin van Hooft; Shinichi Yachida; Satoshi Nara; Nobuyoshi Hiraoka; Kenji Yamao; Susuma Hijioka; Schalk van der Merwe; Michael Goggins; Marcia Irene Canto; Nita Ahuja; Kenzo Hirose; Martin Makary; Matthew J Weiss; John Cameron; Meredith Pittman; James R Eshleman; Luis A Diaz; Nickolas Papadopoulos; Kenneth W Kinzler; Rachel Karchin; Ralph H Hruban; Bert Vogelstein; Anne Marie Lennon
Journal:  Gastroenterology       Date:  2015-08-04       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.